NewMissing Records Detection: flags every visit, provider, and date missing from the file. See how →

MediScan AI vs Enlyte

If you are weighing alternatives, MediScan AI is built for medical-legal professionals and Enlyte is built for insurers and claims organizations. The choice turns on the output you need and how each prices it. Medrecords AI adds a third option: per-page record review with cited deliverables.

Key takeaways

  • MediScan AI is a medical record summaries product for medical-legal professionals. It is best known for summaries and chronologies in minutes with source verification.
  • Enlyte is a claims technology product for insurers and claims organizations. It is best known for a large claims-technology group (mitchell, genex, coventry).
  • Both publish their citation approach differently: MediScan AI says verify source pages per its site, while Enlyte says not stated for record review.
  • Pricing is the fastest filter: MediScan AI is subscription pricing per its site and Enlyte is quote-based.
  • Medrecords AI is the third option: per-page pricing, source-linked output and a drafted chronology, demand or report from the same record set.

Side by side

Vendor pages read 20 Oct 2026
Primary buyer
Medical-legal professionals
Insurers and claims organizations
Law firms, LNCs, claims teams, IME physicians and TPAs
Scope
Editable summaries and chronologies
Claims technology, clinical and network solutions
Record review and cited legal deliverables
Pricing model
Subscription pricing per its site
Quote-based
Per deduplicated page, 10 cents down to 5 cents at volume
Source citations
Verify source pages per its site
Not stated for record review
Every AI answer and chronology entry links to its source line
Formats read
Medical records
Claims and medical records
PDFs, scans, handwriting and DICOM imaging
Security
SOC 2 and HIPAA noted on its [site](https://www.mediscan.ai/).
Formed from Mitchell, Genex and Coventry; awards noted on its [site](https://www.enlyte.com/about).
SOC 2 controls under NDA; HIPAA; BAA and DPA on cloud plans
Trial
Not published
Not published
First case is free on us, no page cap
Best fit
Small teams wanting fast summaries.
Carriers wanting an end-to-end claims platform.
Teams that need a cited deliverable without a platform migration
What MediScan AI does well

Summaries and chronologies in minutes with source verification.

What Enlyte does well

A large claims-technology group (Mitchell, Genex, Coventry).

What is MediScan AI?

MediScan AI is a medical record summaries product for medical-legal professionals. Its published scope covers editable summaries and chronologies. It works with medical records and describes its citation position as verify source pages per its site. On security it lists soc 2 and hipaa noted on its site.. The company was founded in 2023; its public funding and headcount position is $1.4m raised, led by tidal ventures (geekwire). and 10 employees (tracxn).. It is the better fit when small teams wanting fast summaries.

What is Enlyte?

Enlyte is a claims technology product for insurers and claims organizations. Its published scope covers claims technology, clinical and network solutions. It works with claims and medical records and describes its citation position as not stated for record review. On security it lists formed from mitchell, genex and coventry; awards noted on its site.. The company was founded in Not published; its public funding and headcount position is enlyte group raised $4.98b (pitchbook); owned by stone point capital (pitchbook). and 850-1,480 employees (revelio labs and pitchbook).. It is the better fit when carriers wanting an end-to-end claims platform.

Company snapshot

Funding, headcount, traffic, reviews and security from third-party sources, linked where published.

Funding
$1.4M raised, led by Tidal Ventures (GeekWire).
Enlyte Group raised $4.98B (PitchBook); owned by Stone Point Capital (PitchBook).
Team
10 employees (Tracxn).
850-1,480 employees (Revelio Labs and PitchBook).
Traffic
Similarweb shows traffic down 38.61% month over month (Similarweb).
Similarweb global rank about 569K, down 13.68% month over month (Similarweb).
Reviews
Not listed on G2 or Capterra as of 19 Oct 2026.
Not listed on G2 or Capterra as of 19 Oct 2026.
Security
SOC 2 and HIPAA noted on its site.
Formed from Mitchell, Genex and Coventry; awards noted on its site.
Social
Not published.
Active on LinkedIn, X and YouTube.

Where reviewers praise and complain

Independent reviews, where the vendor is listed, in reviewers' own terms. Ratings are point-in-time.

MediScan AI
What reviewers like
  • Summaries and chronologies with source verification
  • Tidal Ventures led its $1.4M round
Where it falls short
  • No review listing
  • Traffic down 38.6% month over month on Similarweb
Enlyte
What reviewers like
  • Mitchell, Genex and Coventry under one claims platform
  • 850-1,480 staff
Where it falls short
  • Quote-only pricing
  • Claims technology, not a record-review tool

What Medrecords AI customers say

Customer calls, shared with permission

These are Medrecords AI customers, not independent reviewers. Quotes come from recorded demos and customer calls, shared with permission.

“I have 12 AI medical record review vendors down here. And of them, this is the one I'm choosing to go with. Number one is the quality of the product. The second is that the cost makes sense.”
Diane, medical malpractice attorney (RN, JD)
“Even an hour to process a full case file is super fast. I was worried it might take 2 or 3 days.”
Brian, IME physician
“It's so refreshing to pay per use instead of a year-long contract. Pretty game-changing.”
Timothy, expert witness consultant
Timothy Richards, expert witness consultant, on the missing records page and duplicate handling. 28-second clip from a recorded customer call.
Customer feedback call, October 2026: "The app is behaving really well, and Bonnie and I are enjoying the experience." 55-second clip, shared with permission.
Why teams choose Medrecords AI
  • Pay per page, not per seat or month: 10 cents down to 5 cents at volume, duplicates free.
  • Every finding links to its source page, including DICOM imaging.
  • First case is free on us, with no page cap and no card.

Where they are cited

MediScan AI: GeekWire and Healthcare IT Today covered its raise.

Enlyte: PitchBook and Revelio Labs profile its scale.

How MediScan AI and Enlyte differ

MediScan AI is a medical record summaries product for medical-legal professionals, with a scope that covers editable summaries and chronologies. Enlyte is a claims technology product for insurers and claims organizations, with a scope that covers claims technology, clinical and network solutions. If those 2 descriptions point at different teams, the decision is mostly about which team owns the file, not which feature list is longer.

On pricing, MediScan AI is subscription pricing per its site, while Enlyte is quote-based. On citations, MediScan AI: verify source pages per its site. Enlyte: not stated for record review. Ask both for a sample where a finding opens the underlying record page, then price the same file.

Feature by feature

Demand and drafting

MediScan AI covers editable summaries and chronologies. Enlyte covers claims technology, clinical and network solutions. If one of those scopes is the exact output your team hands to counsel, that is the faster starting point. If both can produce it, compare the draft, the template flexibility and how many edits the attorney still has to make.

Medical records and chronologies

Ask both to process the same messy record set, including scans, duplicates, handwritten notes and missing pages. MediScan AI works with medical records and says verify source pages per its site. Enlyte works with claims and medical records and says not stated for record review. The output that survives the source-link check is the one worth a contract.

Pricing and contract

MediScan AI is subscription pricing per its site. Enlyte is quote-based. Neither comparison should stop at the monthly figure. Ask whether pricing is per user, case, demand, page or custom; whether revisions and human review are included; whether there are page limits or overages; and what onboarding costs in staff time.

Security and data handling

MediScan AI lists soc 2 and hipaa noted on its site.. Enlyte lists formed from mitchell, genex and coventry; awards noted on its site.. Ask for the BAA, the DPA, where data is stored, how long it is retained, and whether client data is used for model training. A security page is a starting point, not the contract.

Workflow fit

MediScan AI is the better fit when small teams wanting fast summaries. Enlyte is the better fit when carriers wanting an end-to-end claims platform. Medrecords AI is the better fit when the job is a cited chronology plus a drafted demand, IME report or deposition summary, without a platform migration.

Questions to ask on a demo

  • Can we run a real or redacted case, not a vendor sample?
  • How does the tool handle scans, duplicates, handwritten notes and missing pages?
  • Does every chronology entry open the source page and line?
  • What is included in the quoted price, and what is billed extra?
  • Are revisions and human review included?
  • What is the turnaround for a 2,000-page file?
  • Which certifications and BAAs are available, and where is data stored?
  • Is client data used for model training?
  • What export formats are supported?
  • What does onboarding require from our team?

Red flags

  • The demo never shows messy records.
  • The chronology has no source links.
  • Pricing stays vague after 2 calls.
  • There is no clear answer on PHI, BAAs or retention.
  • Revisions or human review are billed without notice.
  • The platform solves a different team's problem.

How to test both on one file

  1. Upload the same record set to MediScan AI, Enlyte and Medrecords AI.
  2. Open the source link behind one chronology entry or summary line in each output.
  3. Compare the draft you would send to counsel, then compare the bill for the same page count.

This is the fastest way to tell a records service from a software platform. The output that survives the citation check is the one worth a contract.

Migration and switching

Switching between MediScan AI, Enlyte and Medrecords AI is less about data export than about trust. Ask each vendor for a named onboarding contact, a sample migration plan, the export formats and a go-live date. Then re-run 3 representative files, including one messy record set, and compare the chronology, the citations and the bill before you cancel anything. A migration that saves a subscription but loses the source trail is not a saving.

Keep the old tool live until one real file has passed the citation check. That single test tells you more than a migration deck, because it shows how the new vendor handles the records your team actually receives.

Who should choose which
Choose MediScan AI when

Small teams wanting fast summaries.

Choose Enlyte when

Carriers wanting an end-to-end claims platform.

Choose Medrecords AI when

You need a cited chronology and a drafted demand package, IME report or deposition summary from a record set, with published per-page pricing and a free first case.

Where Medrecords AI fits

Medrecords AI is not a replacement for MediScan AI when you need a medical record summaries platform, or for Enlyte when you need a claims technology platform. It is the third option for the record-review step: upload a record set, get a source-linked chronology and a drafted demand package, IME report or deposition summary, then review, revise and sign it.

That matters when the bottleneck is the file rather than the firm. Medrecords AI publishes its price at 10 cents per deduplicated page, falling to 5 cents at volume, with duplicates free. It reads PDFs, scans, handwriting and DICOM imaging. First case is free on us, with no page cap and no card.

MediScan AI vs Enlyte: common questions

Which is better, MediScan AI or Enlyte?+

They do different jobs. MediScan AI is built for medical-legal professionals, while Enlyte is built for insurers and claims organizations. Pick the one whose buyer and output match your file, then test both on the same record set.

How do MediScan AI and Enlyte price?+

MediScan AI: Subscription pricing per its site. Enlyte: Quote-based. Medrecords AI publishes 10 cents per deduplicated page, falling to 5 cents at volume, with duplicates free.

Do MediScan AI and Enlyte cite every finding?+

MediScan AI: Verify source pages per its site. Enlyte: Not stated for record review. Medrecords AI links every AI answer and chronology entry to its source line.

Where does Medrecords AI fit?+

Medrecords AI reads the record, cites every finding and drafts the chronology, demand package, IME report or deposition summary. First case is free on us, no page cap and no card.

Which is better for medical chronologies, MediScan AI or Enlyte?+

It depends on the record set. MediScan AI works with medical records and Enlyte with claims and medical records. Ask each to produce a chronology from the same messy file and check the source links.

Which is better for demand packages, MediScan AI or Enlyte?+

MediScan AI covers editable summaries and chronologies. Enlyte covers claims technology, clinical and network solutions. If one of those scopes is the demand workflow you need, start there; otherwise test both on the same file.

Full comparisons

Read each vendor against Medrecords AI on the same buying rows.

Medrecords AI vs MediScan AI →Medrecords AI vs Enlyte →

Bottom line

Choose MediScan AI when small teams wanting fast summaries. Choose Enlyte when carriers wanting an end-to-end claims platform. Choose Medrecords AI when the job is a cited chronology plus a drafted demand, IME report or deposition summary, with published per-page pricing and a free first case.

The worst outcome is buying a platform for a problem your team does not have. Run one real file through each option, open the source behind one finding, and compare the draft you would send to counsel. Decide on the output, the citations and the bill, not the demo.

More MediScan AI comparisons

Sources

Vendor facts come from each vendor's own published pages, read 20 Oct 2026.